Literature DB >> 32960908

The efficiency in the ordinary hospital bed management in Italy: An in-depth analysis of intensive care unit in the areas affected by COVID-19 before the outbreak.

Fabrizio Pecoraro1, Fabrizio Clemente2, Daniela Luzi1.   

Abstract

Since the end of February 2020 a severe diffusion of COVID-19 has affected Italy and in particular its northern regions, resulting in a high demand of hospitalizations in particular in the intensive care units (ICUs). Hospitals are suffering the high degree of patients to be treated for respiratory diseases and the majority of the health structures, especially in the north of Italy, are or are at risk of saturation. Therefore, the question whether and to what extent the reduction of hospital beds occurred in the past years has biased the management of the emergency has come to the front in the public debate. In our opinion, to start a robust analysis it is necessary to consider the Italian health system capacity prior to the emergency. Therefore, the aim of this study is to analyse the availability of hospital beds across the country as well as to determine their management in terms of complexity and performance of cases treated at regional level. The results of this study underlines that, despite the reduction of beds for the majority of the hospital wards, ICUs availabilities did not change between 2010 and 2017. Moreover, this study confirms that the majority of the Italian regions have a routinely efficient management of their facilities allowing hospitals to treat patients without the risk of having an overabundance of patients and a scarcity of beds. In fact, this analysis shows that, in normal situations, the management of hospital and ICU beds has no critical levels.

Entities:  

Mesh:

Year:  2020        PMID: 32960908      PMCID: PMC7508364          DOI: 10.1371/journal.pone.0239249

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

The number of individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing COVID-19 emergency, is dramatically increasing worldwide [1]. The first person-to-person transmission in Italy was reported on February 21st, 2020, and led to an infection chain that represents the largest COVID-19 outbreak outside Asia to date. As of 29th of March 2020, Italy is the second most affected country in the World and the first in Europe, with more than 97.000 confirmed cases according to the Italian Department of Civil Protection [2]. What is still an open question is the reason why the spread of this epidemic has had its most virulent peak in the northern regions of the country [3] leading to a high level of both mortality and fatality rates in comparison to other countries [4, 5] as well as a high contagion and mortality of healthcare workers both in the primary and hospital care [6]. Currently, the 87% of the confirmed actual cases are inhabitants of the northern regions that counts the 55% of the total Italian population. Among them, Lombardia, where the first cases were identified at the end February, is still the region with the majority of individuals infected by the COVID-19 virus. Similar results can be noted considering the hospitalization in general (88% in the northern regions and 42% in Lombardia) and the intensive care units in particular (85% in the northern regions and 35% in Lombardia). This data is provided and daily updated by the Italian Civil Protection Department [7]. These numbers are indicative of the spread of the infection and underline that one of the main challenges to be faced by the National and the Regional Health Systems is the management of hospital resources across the country in terms of professionals, medical devices and hospital beds, with a particular attention on the intensive care unit (ICU) [8]. Given this high demand of hospitalization and critical care, Italian hospitals and in particular those located in the northern regions, have been overloaded. The majority of them are struggling to cope with patients infected by the COVID-19 in addition to those who are hospitalized for other diseases. This has led the actual and past national and regional governments to be heavily criticized for having reduced the number of beds in the past years, in particular those located in the ICUs [9-11]. Different newspapers have highlighted that a reduction in the number of beds has affected many hospitals over the territory. This resource reduction was mainly related to the progressive cutting of the national and local budget in the last decade that led the regional health services to close a significant number of local small dimension hospitals that generally have higher costs [12]. This lack of beds was confirmed by a recent study of the OECD (Organisation for Economic Co-operation and Development) that reported that our country counts 2.6 hospital beds per 1.000 inhabitants [13], ranking Italy at the 19th place over 23 countries with Germany having more than 6 beds per 1.000 inhabitants. However, this data does not specifically consider the ICU. A most recent study reporting the number of beds for the ICU was published by Rhodes et al. in 2012 [14]. Also in this case the number of beds located in Italy was below the European average with 12.9 beds per 100.000 inhabitants, while Germany was equipped with 29.2 beds. The analysis of the Italian National Healthcare Service should consider that health services are organized and delivered under the responsibility of local authorities structured at a regional level, while the Italian Government has a weak strategic leadership [15, 16]. Starting from these premises, the aim of this study is to analyse the Italian regional hospital systems before the outbreak of the COVID-19, in order to assess the efficiency and the performance of the hospital bed management in the past years, so to indicate a reference point for future analysis. Moreover, this study may help to determine if the reduction of hospital resources may have an impact on the functioning of a hospital and on the efficiency in the management of clinical cases [17]. Specific attention is given to the management of the ICU departments. In this perspective, there are two methodologies adopted to assess the efficiency of a health structure in the management of clinical hospitalized cases. The first one is the hospital bed management [18-20] that provides an overall description of the use of beds by health structures. The second methodology evaluates the performance of a hospital considering the complexity of cases treated by the structure [21, 22]. Both methodologies investigate hospital performances providing a helpful snapshot for healthcare managers for the evaluation of healthcare systems [23]. The paper is structured as follows: after the materials and methods paragraph, a brief description of the virus diffusion and workload of the hospital infrastructures is reported on the basis of data available so far to provide an overview of the extraordinary efforts of the Italian health and social care professionals. After that, a comparison of resources availability across the Italian regions is performed to analyse the level of beds reduction in each region. For this analysis we adopted the data captured in the years 2010 and 2017 which are the first and the last available data exposed yearly in the Ministry of Health website [24]. Finally, the results of the hospital bed management analysis are reported to capture the efficiency as well as the complexity and performance of patient hospitalizations.

Materials and methods

Data

This paper is focused on two main data sources. The first one [24] provides daily data on the number of individuals affected by the COVID-19 as well as patients hospitalized in the ward and specifically in the ICUs during the outbreak. This website exposes official and continuously updated information produced by the Italian Civil Protection Department and adopted by the Ministry of Health for its daily bulletin [25]. The second information flow [24] concerns data on hospital bed management. Administrative and clinical data produced during the hospitalization process are collected in Discharge Report Forms and sent by each hospital information system to be centrally gathered by the Ministry of Health. They describe each service provided to a patient as well as facilities available and staff employed in the relevant structure. This information is aggregated and published yearly in the web site of the Ministry of Health [24]. Data analysed in this study refers to the year 2017, the latest most outdated information currently published by the Ministry of Health. Moreover, to examine the differences across years in terms of resources availability and their adoption the analysis has been carried out also on data captured for the year 2010. This study considers both the public and private institutes, excluding the private nursing homes. The datasets gathered from the Ministry of Health website and the relevant analyses performed during the current study are available in the Zenodo repository [26].

Methodologies

The overall description of the hospital bed management is assessed using indicators computed on the basis of the number of beds, the patient discharged over a specific period of time (i.e. a year) and the total number of inpatient days (i.e. the overall number of hospitalization days of all patients) [27]. In particular, the indicators used are defined as follows: Beds Occupancy Rate (BOR): percentage of inpatient beds occupied over a specific period; Average Length Of Stay (AvLOS): average number of days that an inpatients remained in the hospital; Turnover Interval (TOI): number of days in which an available bed remains empty between the discharge of a patient and the admission of a next one; Beds Turn Over (BTO): average number of patients “passing through” each bed during a specific period. We also adopted reference thresholds for TOI (1BOR (85%>BOR>75%) [28-31] to classify each region in the following areas: 1) the red one that identifies regions where both TOI and BOR are outside the reference threshold; 2) the yellow area that reports regions where either TOI or BOR are outside the threshold and 3) the green area that identifies regions where both indicators are within the reference thresholds. The complexity and the performance of each clinical department in the management of clinical hospitalization cases are described, respectively, by the Case Mix (CMI) and the Performance Index (PI). In particular, the former indicates the degree of complexity of clinical cases treated in each hospital with respect to a benchmark level (i.e. the national average), while the PI compares the performance of the observed hospital considering the inpatient length of stays compared to the benchmark level. These indicators are computed according to the following formulas: Where: n: number of wards available the hospital structure; : Italian AvLOS in the specific hospital ward j; : Italian AvLOS considering all hospital wards; : number of patient discharges in Italy in the specific hospital ward j : total number of patient discharges in Italy; : AvLOS in the specific hospital ward j in the relevant structure; : number of patients discharged in the relevant structure in the specific hospital ward j; : total number of patients discharges in the relevant structure. For instance, the two indices for the Lazio region are computed as follows: A high CMI value (Eq 1) indicates a more complex and resource-intensive case load managing of clinical cases. In particular a region with a CMI higher than 1 tends to hospitalize patients in wards with a high average length of stay in comparison to the national benchmark. Conversely, a high PI (Eq 2) value is found when the hospital length of stay is longer than expected. In particular, a region with a PI higher than 1, assuming equal complexity, tends to hospitalize patients for longer periods, thus suggesting lower efficiency relative to the standard [21, 22, 32]. Considering the graphical representation, these indicators are analysed adopting a four-quadrant graph where the CMI is reported in the abscissa and the PI is reported in the ordinate compared to the national benchmark.

Results

Impact of the COVID-19 outbreak in the hospital bed management in Italy

Since the beginning of the contagion, the number of patients infected follows an exponential trend, with a slight change during the last week turning from an exponential to a linear trend (Fig 1). This tendency is evident considering, on the one hand, the total number cases, the number of deaths and healed patients, and, on the other, the number of patients hospitalized in particular in the ICUs. Trends describing hospitalizations are reported in Fig 1 considering both the country as a whole and Lombardia in particular, being the region with the highest number of cases in Italy. These trends highlight the tremendous amount of work carried out by the healthcare professionals to host the exceptional number of patients in the hospital. While all hospital wards are struggling with an exceptional workload due to the COVID-19 outbreak, the ICUs are particularly stressed given that the majority of the hospitals in the northern part of the country are saturating their capacity. Fig 2 summarizes the actual occupancy rate of the ICU beds to date (29th of March 2020). It is important to note that the occupancy rate is computed considering the number of beds available in each region in 2017 and the number of hospitalized patients affected by COVID-19 and does not take into account patients admitted with other pathologies [33]. As highlighted by the colour, different regions have already saturated the hospital beds ordinarily available in their ICUs (Lombardia, Piemonte, Val d’Aosta, Trento, Bolzano), with other regions worryingly approaching this threshold (Marche, Emilia Romagna, Toscana, Liguria). It is to be noted that, all of them are located in the northern part of Italy.
Fig 1

Number of patients hospitalized in the Italian regions and in Lombardia by COVID-19 wards and Intensive Care Units [7].

Fig 2

Percent of routinely available beds in the Intensive Care Units occupied by COVID-19 patients by region.

Colours indicate the level of bed occupancy rate spanning from red (high % of beds occupied) and green (low % of beds occupied).

Percent of routinely available beds in the Intensive Care Units occupied by COVID-19 patients by region.

Colours indicate the level of bed occupancy rate spanning from red (high % of beds occupied) and green (low % of beds occupied). For the time being, it is difficult to analyse the local health system management responses to the COVID-19 crisis as different components have to be considered including measures of lockdown, population characteristics, resources available in terms of health professionals, equipment, territorial services, etc. However, the analysis carried out in the next sections is in our opinion an important reference point to further analyse how and to what extent the health system reacted to this pandemic period.

Analysis of the Italian structural components

In this paragraph data collected in the years 2010 and 2017 is compared to capture differences in terms of beds availability, number of hospitalizations and total number of inpatient days. A highlighted in Table 1, an important reduction of the hospital beds is shown all over the Italian regions. This reduction matches with a reduction of both number of inpatients and total number of days spent in the hospital. Differences across the country indicate the highest level of reductions in the southern regions. Considering the northern regions heavily affected by the COVID-19, the reduction ranges from -5% in Bolzano and Val d’Aosta to -23% in Trento, while Lombardia cuts around the 7% of hospital beds.
Table 1

Number of hospital beds, hospitalization and length of stay in the years 2010 and 2017 highlighting the differences in each Italia region.

All hospital wards20102017% difference 2017–2010
BedsInpatientsLength of StayBedsInpatientsLength of StayBedsInpatientsLength of Stay
Abruzzo368814035510440542966118111902896-20%-16%-14%
Basilicata172361958464549165457352446263-4%-7%-4%
Calabria423117013711566583168129178923884-25%-24%-20%
Campania11423485809322870698993896612827162-13%-20%-12%
Emilia Romagna142785264364231655128084938103753721-10%-6%-11%
Friuli Venezia Giulia3931132046109252435041321051011899-11%0%-7%
Lazio164726000014905223142134899194016779-14%-18%-18%
Liguria5775198075173865848471778251507474-16%-10%-13%
Lombardia3021610858838644011280479529307956351-7%-12%-8%
Marche4802177308134910939691451611151105-17%-18%-15%
Molise133548710370750106333597263986-20%-31%-29%
Piemonte131754430313984466116043814203394503-12%-14%-15%
P.A. Bolzano166066503467972157861154445617-5%-8%-5%
P.A. Trento175650846439402135351594400525-23%1%-9%
Puglia11971488098337621593063730402751312-22%-24%-19%
Sardegna4834181711128867741391522471120080-14%-16%-13%
Sicilia113484765753287241102003659113043748-10%-23%-7%
Toscana10719431772296021391393724402603535-15%-14%-12%
Umbria252111788877768825651027237823402%-13%1%
Valle d’Aosta4011434011940037913506108196-5%-6%-9%
Veneto162365276774735739146385004224244400-10%-5%-10%
Total172495642515949662910151039549410643655776-12%-14%-12%
A different picture is shown focusing on the ICUs. Table 2 highlights that the number of beds in these departments has not changed in the period considered, on the contrary there was an increase of around 6% in the number of beds all over the territory. Remarkably, differences across regions can be detected, even if only five regions have reduced the number of intensive care beds with the highest cut of 5% in Lazio, Liguria and Piemonte.
Table 2

Number of hospital beds, hospitalization and length of stay in the years 2010 and 2017 in the intensive care units highlighting the differences in each Italian region.

Intensive care unit hospital ward20102017% difference 2017–2010
BedsInpatientsLength of StayBedsInpatientsLength of StayBedsInpatientsLength of Stay
Abruzzo91110518566921198177231%8%-5%
Basilicata416981057649745978220%7%-8%
Calabria10716662493112427412923716%65%17%
Campania36372399464942765029161618%-10%-3%
Emilia Romagna372371053817360420151943-3%13%-3%
Friuli Venezia Giulia10317431442411919361613216%11%12%
Lazio510477098347486469991136-5%-1%-7%
Liguria173184328332164149125157-5%-19%-11%
Lombardia66367759205773876419166111%13%0%
Marche11316081888512715381982612%-4%5%
Molise29413693035496698021%20%1%
Piemonte316342850239299346844595-5%1%-11%
P.A. Bolzano3661672053761245923%-1%-36%
P.A. Trento20272267331369362855%36%36%
Puglia19738915389523138845640417%0%5%
Sardegna10716142544512016952243612%5%-12%
Sicilia336524073888323511876188-4%-2%3%
Toscana32234154995937339115609216%15%12%
Umbria61683861569730891413%7%3%
Valle d’Aosta811891110118127325%0%40%
Veneto4484851681424684777648134%-2%-5%
Total4416556988024864682578707901286%4%-2%
A focus on the reduction of the hospital beds in the different wards is reported in Table 3 highlighting those covering the 90% of the hospitalization complexity in terms of the average length of stay. In particular, oncology and ICUs have had an increase in the number of beds in Italy, while in other wards the reduction was even more than 20%, among which surgery, paediatrics and otolaryngology. This indicates that, among the wards that manage complex clinical cases, the availability of hospital beds in the ICUs was not affected by the funding cuts to public health. These crude differences may also be due to the tendency, widespread in the last years in many European countries, of adopting policies that strongly shift the organization and provision of health and social services from formal institutional facilities (e.g. hospitals) to home care [34]. Moreover, recently the provision of different scheduled procedures (e.g. diagnostic test, clinical examinations, treatments) are mainly provided on a day hospital basis, reducing the number of beds needed to treat the patients.
Table 3

Number of beds in the years 2010 and 2017 highlighting the differences in each hospital ward.

Beds available in each hospital ward20102017% Difference 2010–2017ICM reference value
General medicine3011826053-13%0,20
General surgery1985415889-20%0,11
Orthopaedics and traumatology1431412063-16%0,08
Obstetrics and gynaecology1300010934-16%0,07
Function recovery and rehabilitation100499708-3%0,06
Cardiology67596687-1%0,05
Long-term patients51354067-21%0,03
Neurology52224944-5%0,03
Paediatrics57464578-20%0,03
Geriatrics40613550-13%0,03
Urology51394501-12%0,03
Psychiatry41724032-3%0,03
Pneumology37773186-16%0,02
Oncology270327592%0,02
Infectious and tropical diseases31542816-11%0,02
Neurosurgery27332454-10%0,02
Intensive care441646826%0,02
Otolaryngology34082549-25%0,02
Neonatology19441913-2%0,01
Nephrology20491913-7%0,01
Neuro-rehabilitation19811855-6%0,01
Gastroenterology17161616-6%0,01
Other differences related to the availability of hospital beds refer to their distribution in the 21 regions and autonomous provinces. Fig 3 reports the number of beds per 100.000 inhabitants considering all disciplines (A) and focusing on the intensive care unit departments (B). The proportions vary across the country spanning from Molise that counts the highest values for both categories to Calabria that displays the lowest proportions. Summarizing, southern Italy (e.g. Abruzzo, Calabria, Campania, Puglia, Sicilia) suffers the lack of hospital beds and lays in the middle of the rank with 279 beds in total and 8 intensive care unit beds per 100.000 inhabitants, as shown in Fig 3.
Fig 3

Number of total and intensive care unit beds per 100000 inhabitants in the different Italian regions.

Hospital bed management

Table 4 reports the results obtained for each region highlighting the classification in the areas of hospital bed management as well as case-mix and performance indicators. Green cells highlight region where the indicators are above the relevant threshold (i.e. BOR between 75% and 85% and TOI between 1 and 3 days). Note that while BOR and TOI thresholds are from the literature [26-29], those for the AvLOS and BTO are computed on the basis of the national average given that reference values for these indicators strictly depend on the distribution of the admissions in the different hospital wards. For instance, in Italy, the average length of stay in the otolaryngology ward is around 4 days, in the cardiology ward is around 6 days, whereas in the ICU is around 14 days. This difference also influences the bed turn over that indicates the number of patients per bed hospitalized during the year.
Table 4

Cross-regional comparison of the results of bed management as well as complex and performance analysis.

All hospital wardsTOIBORAvLOSBTOCMIPI
Abruzzo1,5283%7,6439,821,020,97
Basilicata2,7574%7,7834,671,030,97
Calabria1,8080%7,1540,780,950,98
Campania2,0278%7,2639,360,940,99
Emilia Romagna1,8780%7,6038,551,020,96
Friuli Venezia Giulia2,0279%7,6637,701,011,00
Lazio2,3977%8,2034,470,961,08
Liguria1,4785%8,4836,691,081,01
Lombardia2,3978%8,3533,981,031,04
Marche2,0579%7,9336,570,961,06
Molise3,6968%7,8631,611,031,02
Piemonte2,2080%8,9032,871,031,10
P.A. Bolzano2,1377%7,2938,750,990,93
P.A. Trento1,8181%7,7638,131,010,98
Puglia1,7381%7,3840,090,950,99
Sardegna2,5774%7,3636,780,971,05
Sicilia1,8682%8,3235,870,971,08
Toscana1,9778%6,9940,751,000,91
Umbria1,5084%7,6240,051,040,94
Valle d’Aosta2,2378%8,0135,641,021,08
Veneto2,2079%8,4834,191,031,04
Total2,0979%7,9536,38  
Considering the hospital bed management, all regions fall within the threshold values both for the BOR and the TOI, with the exception of Molise, Basilicata and Sardegna. Regional differences can be captured considering both AvLOS and BTO. The first one indicates regions (i.e. Lombardia and Liguria) that tend to extend the patient’s hospital stays when compared to the national benchmarking value, while BTO captures regions (i.e. Lombardia and Molise) with a low number of patients as a percentage of available beds. The difference in the AvLOS across the country can determine the level of performance of each region on the basis of the complexity of cases. On the basis of these analyses, regions are classified in the following four macro-clusters, that mainly represent the classification of the complex and performance indicators (Fig 4):
Fig 4

Overall classification of each Italian region considering both the hospital bed management indicators and the complexity and performance indicators.

In both figures the colour of the marker captures the hospital bed management classification. In the Italian map, regions are coloured on the basis of the ratio between the CMI and PI.

Six regions (Abruzzo, Emilia Romagna, Trento, Toscana, Umbria e Basilicata) reported positive results in the management of hospital beds. These regions report high performances in the treatment of complex cases, mainly due to short hospitalization with respect to the national average length of stay. The second group of regions (Calabria, Campania, Bolzano e Puglia) has similar results compared to the above cluster, with hospitalizations efficiently managed with high performances. Differently from the above-mentioned group, these regions tend to manage cases that are less complex. Six regions (Friuli Venezia Giulia, Piemonte, Valle D’Aosta, Veneto, Liguria e Lombardia) manage the hospital beds with a high turnover and beds that remain scarcely empty during the year. This is mainly due to a high length of stay that results in a low level of performance compared to the national level, even if these regions mainly manage complex cases. The last group is composed by four regions (Lazio, Marche, Sicilia e Sardegna). Even if they have positive values in the hospital bed turnover and turnover interval, the performance is lower than the national reference value also considering that these regions tend to manage fewer complex cases.

Overall classification of each Italian region considering both the hospital bed management indicators and the complexity and performance indicators.

In both figures the colour of the marker captures the hospital bed management classification. In the Italian map, regions are coloured on the basis of the ratio between the CMI and PI. In this classification Molise represents an interesting outlier. It is the only region with both BOR and TOI outside the efficiency thresholds. This result may be associated with the high number of hospital beds per 100.000 inhabitants, that is the highest number across the 21 Italian regions. These features contribute also to the performance of the regional hospitals even if this region tends to manage complex cases. To further detail this analysis, intensive care unit beds and hospitalization flow were analysed. Table 5 reports the results of the hospital bed management, complexity and performance indicators. Also in this case, green cells identify regions where the CMI and/or the PI values are above the benchmarking level (i.e. CMI higher than 1, PI lower than 1). In this analysis the thresholds for the four hospital bed management indicators are defined on the basis of the national average values, given that no reference values specifically focused on the ICU bed management are available in the literature. The macro-clusters detected on the basis of both analyses are summarized in the following (Fig 5):
Table 5

Cross-regional comparison of the results of bed management as well as complex and performance analysis of intensive care units.

Intensive Care UnitTOIBORAvLOSBTOCMICPI
Abruzzo13,2453%14,7913,020,971,14
Basilicata10,8855%13,1315,201,251,02
Calabria5,8565%10,6722,102,050,81
Campania9,8859%14,0915,231,581,04
Emilia Romagna18,9140%12,3611,670,810,91
Friuli Venezia Giulia14,1037%8,3316,271,390,62
Lazio18,3651%19,399,670,911,42
Liguria23,2742%16,879,090,801,24
Lombardia23,2634%12,0010,350,760,88
Marche17,2543%12,8912,111,010,95
Molise11,6855%14,0714,171,411,14
Piemonte18,6141%12,8611,600,860,95
P.A. Bolzano14,5634%7,5016,540,960,60
P.A. Trento20,8332%9,8311,900,680,75
Puglia7,1967%14,5216,810,981,08
Sardegna12,6051%13,2414,131,050,98
Sicilia8,1565%14,8915,851,331,09
Toscana20,4741%14,3410,491,001,05
Umbria22,2935%12,2110,580,670,91
Valle d’Aosta20,1435%10,7911,800,850,87
Veneto22,1938%13,5710,210,901,00
Total15,8846%13,6512,36  
Fig 5

Overall classification of each Italian region considering both the hospital bed management indicators and the complexity and performance indicators of intensive care units.

In both figures the colour of the marker captures the hospital bed management classification. In the Italian map, regions are coloured on the basis of the ratio between the CMI and PI.

In three regions (Calabria, Sardegna e Sicilia) all indicators report positive values, when considering the national average ones. They manage complex cases with high performance results. The quick turnover and a high percentage of bed occupancy make these regions efficient also in the management of ICU beds. A consistent number of regions (Basilicata, Campania, Molise, Sicilia, Abruzzo, Puglia e Lazio) belong to the second cluster. As reported for the previous group, these regions have a high bed turnover and the number of days between two hospitalization are relatively low. Differently from the above-mentioned group, these results are mainly due to the high number of days that patients spend in the ICU. For this reason, even if these regions tend to cope with complex cases and pathologies, their performance is lower than the national one. In three regions (Liguria, Toscana e Veneto) hospital beds are not efficiently managed with a low performance in the management of not so complex cases. This is mainly due to the low complexity of cases with a length of stay higher than the national average value. In the last group of regions (Emilia Romagna, Lombardia, Piemonte, Trento, Umbria, Val D’Aosta, Bolzano) the majority of the hospitalization cases are not efficiently managed with a high value of length of stay for not complex cases.

Overall classification of each Italian region considering both the hospital bed management indicators and the complexity and performance indicators of intensive care units.

In both figures the colour of the marker captures the hospital bed management classification. In the Italian map, regions are coloured on the basis of the ratio between the CMI and PI. In this classification Marche represents an outlier in the management of hospital beds. Differently from the last reported cluster, this region manages complex cases with a relative high performance.

Discussion and conclusions

COVID-19 is one of the most serious pandemics of the past 100 years, its rapid global spread is overwhelming hospitals and local communities in Italy and worldwide. One of the main challenges is to rapidly and efficiently assign and reallocate appropriate resources, such as medical professionals, equipment, hospital beds to face overload and saturation. For these reasons, the analysis of hospital capacity and the efficiency in the management of its structures before the emergency outbreak provides an important reference point to further explore how the management of the emergency has been carried out. Moreover, on this basis lessons learned outlining structural bottle necks and/or facilitators could give indications on the best way to achieve hospital disaster preparedness in case of a COVID-19 second wave or other possible pandemics [35]. On the basis of the recent financial cuts of public health facilities, this paper analyses the efficiency in the management of hospital beds across Italian regions. The results of the overall analysis firstly show that even if an important reduction of hospital beds affected the majority of the hospital wards, an opposite trend has been detected for the ICUs that are particularly stressed in a respiratory pandemic crisis. This is particularly evident considering the regions that are most effected by the virus where the number of ICU beds has increased in recent years (i.e. between 2010 and 2017): Lombardia +11%, Marche +12%, Piemonte -5%, Trento +55%, Bolzano +3%, Veneto +4%. Hospital beds are generally efficiently managed all over the country with some exceptions in the south of Italy that show a slow turnover and/or a low bed occupancy rate. The Italian northern regions show instead that cases are handled with rapid shifts and without leaving beds empty during the year. Moreover, generally northern regions mainly deal with complex cases, albeit with a performance below the national average. On the contrary, different results are displayed analysing the management of beds in the intensive care units, where the 75% occupancy rate threshold is not reached in all regions. In this sense, the northern regions exhibit a high performance, even if related to the management of less complex cases that can be related to a large patient mobility towards hospitals located in the northern regions especially for elective treatments. Moreover, there was no substantial reduction of beds in ICUs, if compared to relevant financial cuts in other wards. This trend may be explained by the attempt to reorganizing the national public health reducing hospital costs at the same time. On the one hand, the provision of health services is increasingly shifting from formal institutional facilities (e.g. hospitals) to home care and, on the other hand, different scheduled procedures are mainly provided on a day hospital basis reducing the number of beds needed to treat the patients. The majority of the Italian regions and in particular those in the northern part of the country can rely on an appropriate number of beds that generally do not saturate in normal periods. The availability of hospital beds as well as the efficiency in their management confirmed in this study allow hospitals to treat patients without the risk of having an overabundance of patients and a scarcity of beds. In fact, the analysis reported in this paper showed that, in normal situations, the management of hospital has no critical levels. This is particularly evident considering the ICU wards where the BOR is lower than 67% in all regions and even lower in the regions that have saturated the ICU beds during the epidemics spread: Lombardia 34%, Marche 43%, Piemonte 41%, Trento 32%, Bolzano 34%, Veneto 38%. During pandemic or other catastrophic periods, the hospital management paradigms need to be changed [36] making it necessary to balance the relationship between hospital and territory as well as to determine the appropriate allocation of inpatient resources [37]. The availability of hospitalization data as well as the continuous change in terms of bed availability across the Italian regions make it difficult to apply this methodology in this pandemic period yet. However, an ex post analysis that relies in updated and robust data should be applied in the future to provide indications on the hospital-territory relationship in response citizens’ safety and wellbeing. 9 Jun 2020 PONE-D-20-09436 The efficiency in the ordinary hospital bed management in Italy: an in-depth analysis of intensive care unit in the areas affected by COVID-19 before the outbreak PLOS ONE Dear Dr. Pecoraro, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by 05 JUL 2020. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Maria Michela Gianino Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please refer to the specific statistical analyses performed in your Methods section; and illustrate the results of such analysis in more detail in the Results (for more information, please see https://journals.plos.org/plosone/s/submission-guidelines.#loc-statistical-reporting). Moreover, please provide more background on the choice of using the year 2010 as a control. 3. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service. Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services.  If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free. Upon resubmission, please provide the following: The name of the colleague or the details of the professional service that edited your manuscript A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file) A clean copy of the edited manuscript (uploaded as the new *manuscript* file) 4. We note that Figure 2 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission: a. You may seek permission from the original copyright holder of Figure 2 to publish the content specifically under the CC BY 4.0 license. We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text: “I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].” b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only. The following resources for replacing copyrighted map figures may be helpful: USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/ The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/ Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/ Landsat: http://landsat.visibleearth.nasa.gov/ USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/# Natural Earth (public domain): http://www.naturalearthdata.com/ [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: “The efficiency in the ordinary hospital bed management in Italy: an in-depth analysis of intensive care unit in the areas affected by COVID-19 before the outbreak” presents an analysis of bed availability in Italy prior to the epidemic. It concludes that bed supply was adequate and utilized efficiently at this time. Another important question is whether bed supply was adequate to match demand due to the pandemic. Obviously, the demand increased by such large amounts that it was not adequate especially in northern regions. It would be informative for the authors to extend their analysis to address this question. Also, I found the paper confusing and overly detailed in parts. Some specific comments/questions include: • Provide examples of the calculation of CMI and PI, perhaps in an appendix. Provide a clearer explanation of Figure 2. I assume the numbers within each region represent N of Covid19 pts/N of ICU beds. If so the title could be revised to read, “Percent of routinely available beds occupied by COVID-19 patients by region. Colours indicate ...” • What is the definition of a specialty (j)? It would be better to do a case-mix adjustment using the diagnosis/DRG of individual patients to provide more sensitivity to differences among regions. Even better would be to add an admission severity of illness score to the diagnosis. If data aren’t available to do this, this limitation in the case-mix adjustment method should be stated. • Is there any audit or other mechanism to ensure reliability of source data? If not, is there any evidence that there may be differences in diagnostic coding or other data elements among regions? • Table 1 columns don’t line up with headings. And are the total percentages at the bottom simple or weighted averages? • On Lines 211-212 it states, “indicators are above the relevant threshold”. The authors should be explicit about the threshold. They should also be consistent. One line 242 they state, “Also in this case, green cells identify efficient regions.” Is this what is meant by “above the relevant threshold”? • On Line 212 it states “BOR and TOI thresholds are captured in the literature”. What literature are you citing? • On Line 135 the term “efficacy” is used. I think the authors mean “efficiency” here? If not, “efficacy” should be defined and how it’s measured made explicit. • Putting “High” and “Low” on Figure 4 and Figure 5 would help the reader know which is the desirable direction. • There are several grammatical errors, for example the disagreement of the singular nouns and plural verbs in the following: o 57 highlighted that a reduction in the number of beds have affected many hospitals over the territory. o 64 was published by Rhodes et al in 2012 [7]. Also in this case the number of beds located in Italy are o 239 regional hospitals even if this region tend to manage complex cases. Reviewer #2: The topic is relevant in terms of the present global pandemic situation. However, the aim of this research is not adequate in terms of an international journal perspective. Data presented using summary statistics is useful, but inclusion of bar charts and graphs whilst comparing the data could be more relevant. Line 68 ......ending with 'Government has a weak strategic leadership' - Ref required In general, discussion is too short; there are more points/results to be discussed and more references needs to be included rather than giving vague statements. Discussion and conclusion could be separated ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Dr. A Peter [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. 20 Jul 2020 Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at: https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please refer to the specific statistical analyses performed in your Methods section; and illustrate the results of such analysis in more detail in the Results (for more information, please see https://journals.plos.org/plosone/s/submission-guidelines.#loc-statistical-reporting). Moreover, please provide more background on the choice of using the year 2010 as a control. Author’s response: The quantitative analysis proposed in this paper is based on a computation of indices with the aim of assessing the efficiency of hospital bed management and the complexity of cases treated. A proper statistical analysis (regression, analysis of variance, etc.) is not applied, while the trend of those indices between available data (year 2010 and 2017) has been considered and discussed. Considering the choice of year 2010 as a control, we compared 2017 with 2010 as they are the last and the first data available from Italian Ministry of Health. 3. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service. Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services. If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free. Upon resubmission, please provide the following: • The name of the colleague or the details of the professional service that edited your manuscript • A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file) • A clean copy of the edited manuscript (uploaded as the new *manuscript* file) Author’s response: All the authors carefully read and improved the manuscript which was also revised by a professional mother tongue translator appointed by IRPPS. 4. We note that Figure 2 in your submission contain [map/satellite] images which may be copyrighted. Author’s response: The map reported in Table 2 has been changed adopting a figure downloaded from the Wikipedia website and painted by authors. The file, as stated by Wikipedia, is in the public domain and the author should “grant anyone the right to use this work for any purpose, without any conditions, unless such conditions are required by law”. https://it.wikipedia.org/wiki/File:Italy_map_with_regions.svg Reviewers' comments. Reviewer #1: “The efficiency in the ordinary hospital bed management in Italy: an in-depth analysis of intensive care unit in the areas affected by COVID-19 before the outbreak” presents an analysis of bed availability in Italy prior to the epidemic. It concludes that bed supply was adequate and utilized efficiently at this time. Another important question is whether bed supply was adequate to match demand due to the pandemic. Author’s response: We improved the discussion and conclusions paragraph to underline this aspect. Starting from the results of the hospital bed management analysis it is clear that the majority of the Italian regions can rely on an appropriate number of beds that generally do not saturate in normal periods. This is true also considering the ICU wards. Of course, during pandemic or other catastrophic periods, the hospital management paradigms need to be changed making it necessary to balance the relationship between hospital and territory as well as to determine the appropriate allocation of inpatient resources. However, to apply this methodology in this pandemic period it is necessary to perform an ex post analysis that relies in updated and robust data. In our view the analysis we performed has to be taken into account when considering local health management responses to pandemics. Obviously, the demand increased by such large amounts that it was not adequate especially in northern regions. It would be informative for the authors to extend their analysis to address this question. Also, I found the paper confusing and overly detailed in parts. Some specific comments/questions include: Author’s response: The text and style of the paper was improved. • Provide examples of the calculation of CMI and PI, perhaps in an appendix. Author’s response: Now an example of how the two indices are computed for a given region (i.e. Lazio) is reported in the M&M section. We also included additional references to better explain these indices. • Provide a clearer explanation of Figure 2. I assume the numbers within each region represent N of Covid19 pts/N of ICU beds. If so the title could be revised to read, “Percent of routinely available beds occupied by COVID-19 patients by region. Colours indicate ...” Author’s response: Caption of figure 2 has been changed taking into account the reviewer’s suggestion. The actual version is: Figure 2. Percent of routinely available beds in the Intensive Care Units occupied by COVID-19 patients by region. Colours indicate the level of bed occupancy rate spanning from red (high % of beds occupied) and green (low % of beds occupied). • What is the definition of a specialty (j)? It would be better to do a case-mix adjustment using the diagnosis/DRG of individual patients to provide more sensitivity to differences among regions. Even better would be to add an admission severity of illness score to the diagnosis. If data aren’t available to do this, this limitation in the case-mix adjustment method should be stated. Author’s response: “Specialty” has been replaced with “ward” as the CMI and PI indices are computed taking into account the availability of beds and the hospital discharges in each hospital ward. Note that in the Italian hospital system each ward correspond to a clinical speciality. Considering data availability, information is extracted from a national data bank that exposes data aggregated by hospital facility and hospital ward. Moreover, the CMI and PI indices are based on hospital wards where the patients are hospitalized instead of DRGs. This part of the M&M has been updated to clarify the type of data source available and the methodology adopted to compute the indices. • Is there any audit or other mechanism to ensure reliability of source data? If not, is there any evidence that there may be differences in diagnostic coding or other data elements among regions? Author’s response: We elaborated data gathered from two data sources. The first one regards the hospital bed management and considers the Discharge Report Form sent by each hospital to the relevant region and then to the Italian Ministry of Health. This data are gathered and exposed by the Ministry of Health in its website and this information flow is part of the NSIS New Health Information System (NSIS) developed and managed by law by the Ministry of Health. In this work, as these official data are aggregated for clinical wards, we did not consider the diagnostic code (ICD or DRG), but we took into account the hospital ward where the patient has been admitted. The second source of information provides daily data on the virus diffusion during the COVID-19 outbreak. It exposes official and continuously updated information produced by the Italian Civil Protection Department and adopted by the Ministry of Health for its periodic bulletin (http://www.salute.gov.it/portale/nuovocoronavirus/archivioNotizieNuovoCoronavirus.jsp). • Table 1 columns don’t line up with headings. And are the total percentages at the bottom simple or weighted averages? Author’s response: Now the heading of Table 1 has been updated. The last raw represents values of Italy, thus it is not a simple average, but it highlights weighted differences in the whole country. • On Lines 211-212 it states, “indicators are above the relevant threshold”. The authors should be explicit about the threshold. They should also be consistent. Author’s response: We added thresholds for the BOR and TOI indices as well as the relevant references. • One line 242 they state, “Also in this case, green cells identify efficient regions.” Is this what is meant by “above the relevant threshold”? Author’s response: We added thresholds for the CMI and PI indices as well as the relevant references. • On Line 212 it states “BOR and TOI thresholds are captured in the literature”. What literature are you citing? Author’s response: We added reference to specify thresholds of indices. • On Line 135 the term “efficacy” is used. I think the authors mean “efficiency” here? If not, “efficacy” should be defined and how it’s measured made explicit. Author’s response: The correct term is efficiency. Authors apologise for these errors. • Putting “High” and “Low” on Figure 4 and Figure 5 would help the reader know which is the desirable direction. Author’s response: Figure 4 and figure 5 have been updated on the basis of the reviewer’s suggestion • There are several grammatical errors, for example the disagreement of the singular nouns and plural verbs in the following: o 57 highlighted that a reduction in the number of beds have affected many hospitals over the territory. o 64 was published by Rhodes et al in 2012 [7]. Also in this case the number of beds located in Italy are o 239 regional hospitals even if this region tend to manage complex cases Author’s response: The text has been further revised and improved by the authors and revised by a professional mother tongue translator. Reviewer #2. The topic is relevant in terms of the present global pandemic situation. However, the aim of this research is not adequate in terms of an international journal perspective. Author’s response: This paper is focused on the Italian regions considering the impact of the virus on the Italian population in the first phase of the spread in Europe. Moreover, the results of this analysis may be adopted and extended to other countries in Europe to capture the importance of the availability of hospital resources to limit the spread of the virus and to care for patients with COVID-19. The aim as well as the hypothesis of the paper have been clarified in the updated version of the abstract and introduction. Moreover, the findings of the research have been further explored and argued in the discussion paragraph. Data presented using summary statistics is useful, but inclusion of bar charts and graphs whilst comparing the data could be more relevant. Author’s response: The paper has already a five diagrams and five figures. Moreover, we charted all the data reported in the tables to highlight results of the hospital bed management analysis. However, if the reviewer and the editor suggest additional data to be charted or graphed we are willing to graph them. • Line 68 ......ending with 'Government has a weak strategic leadership' - Ref required. Author’s response: Two references explaining this sentence have been added in the manuscript. They are: • Lo Scalzo A, Donatini A, Orzella L, Cicchetti A, Profi li S, Maresso A. Italy: Health system review. Health Systems in Transition. 2009; 11(6)1-216. • Armocida B, Formenti B, Ussai S, Palestra F, Missoni E. The Italian health system and the COVID-19 challenge. The Lancet Public Health. 2020; 5(5), e253. • In general, discussion is too short; there are more points/results to be discussed and more references needs to be included rather than giving vague statements. Author’s response: Discussion and conclusions paragraph has been improved. • Discussion and conclusion could be separated Author’s response: We prefer to maintain discussion and conclusions in the same paragraph to give more continuity to the presentation of findings. Submitted filename: Response to the Reviewers Paper hospitalization_PLOS.docx Click here for additional data file. 3 Sep 2020 The efficiency in the ordinary hospital bed management in Italy: an in-depth analysis of intensive care unit in the areas affected by COVID-19 before the outbreak PONE-D-20-09436R1 Dear Dr. Pecoraro, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. The decision depended on the following considerations: - The authors have substantially clarified the presentation of their paper and the have provided a detailed response to each reviewer/editorial point raised -  Reviewer 1 proposed a major revison by proposing “ It would be better to do a case-mix adjustment using the diagnosis/DRG of individual patients to provide more sensitivity to differences among regions. Even better would be to add an admission severity of illness score to the diagnosis. If data aren’t available to do this, this limitation in the case-mix adjustment method should be stated.” The reviewer therefore suggested using DRGs, but if the data were not available, the reviewer suggests to insert this lack as a limit. The reviewer did not make this adjustment binding. - There are reviewers' comments on the validity of some indicators: “In addition, the measure of performance, bed occupancy rate, can be affected by other factors such as substitutability (e.g. an obstetrics patient can’t be put in infectious disease unit and vice-versa), regional differences in demand patterns (e.g. resort areas have more fluctuation over the year), and the size of a ward.” However, these indicators have not undergone a major revision. -          While agreeing that the case-mix can represent a limitation, the article addresses a health policy problem that is particularly debated in Italy. As a consequence of the Ministerial Decree / 70, an intervention was carried out to reduce the number of beds in hospitals throughout Italy. With the COVID emergency, hospitalizations have increased and the difficulty of hospitals has been attributed to the DM / 70. The article assesses whether this widespread opinion is acceptable. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Carmen Melatti Staff Editor PLOS ONE on behalf of Maria Michela Gianino Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: No Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have substantially clarified the presentation of their paper. However, as I thought might be the case in my previous comments, I believe the case-mix analysis is not sensitive enough to make a valid assessment of a region’s complexity and performance as it is done at too high a level of aggregation: the ward or specialty. There can be considerable differences in case-mix within a ward that can be masked when using ward as a covariate to adjust for measures such as LOS or bed turnover.  For example, a region that has a high rate of referrals from other regions may appear to have low performance as a result of receiving a high proportion of complex cases relative to other regions. This would not be sufficiently captured by using ward as the adjustment variable. A patient admitted to the cardiac ward in region A with a mild heart attack would be equivalent to one admitted to region B with a more severe heart attack exacerbated by comorbidities such as diabetes. As documented in the literature on risk adjustment, to capture these differences among regions would require case-mix analysis at a DRG level at minimum and preferably with severity adjustment as well. In addition, the measure of performance, bed occupancy rate, can be affected by other factors such as substitutability (e.g. an obstetrics patient can’t be put in infectious disease unit and vice-versa), regional differences in demand patterns (e.g. resort areas have more fluctuation over the year), and the size of a ward. The latter is probably the most important factor that needs to be considered as the larger the ward the smaller the coefficient of variation and thus the higher the occupancy rate it can maintain while still having enough beds to admit urgent patients. Without using ward size (or at least individual hospital size) occupancy rate comparisons can be very misleading. Finally, there are still a few grammatical or word choice errors: Line 108 – I believe the authors mean “most up to date” rather than “most outdated” Line 209 – “institutions” is the correct word, not “institutes” Line 185 – “reacted to this pandemic period” is stated; however, the data in the next section are from a period prior to the pandemic Line 195 – “data” is a plural term so the verb should be “are” Reviewer #2: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Dr. A Peter 11 Sep 2020 PONE-D-20-09436R1 The efficiency in the ordinary hospital bed management in Italy: an in-depth analysis of intensive care unit in the areas affected by COVID-19 before the outbreak Dear Dr. Pecoraro: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Maria Michela Gianino Academic Editor PLOS ONE
  22 in total

1.  [Barber and Johnson diagram and latent reserve as tools to optimise the management of hospital beds].

Authors:  V A Pulgar Perera; M T Paniagua Tejo; S Sañudo García
Journal:  J Healthc Qual Res       Date:  2019-05-16

2.  Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.

Authors:  Graziano Onder; Giovanni Rezza; Silvio Brusaferro
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

3.  Trend and determinants of acute inpatient care for the elderly in Italy from 2001 to 2011.

Authors:  G Liotta; F Gilardi; P Scarcella; S Orlando; S Mancinelli; E Buonomo; M C Marazzi; L Palombi
Journal:  Ann Ig       Date:  2016 Sep-Oct

4.  Coronavirus Disease 2019 (COVID-19) in Italy.

Authors:  Edward Livingston; Karen Bucher
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

5.  Application of case mix index in the allocation of nursing human resources.

Authors:  Binru Han; Xi Chen; Qiuping Li
Journal:  J Nurs Manag       Date:  2018-02-23       Impact factor: 3.325

Review 6.  Efficiency and optimal size of hospitals: Results of a systematic search.

Authors:  Monica Giancotti; Annamaria Guglielmo; Marianna Mauro
Journal:  PLoS One       Date:  2017-03-29       Impact factor: 3.240

7.  Deaths from COVID-19 in healthcare workers in Italy-What can we learn?

Authors:  Pierfrancesco Lapolla; Andrea Mingoli; Regent Lee
Journal:  Infect Control Hosp Epidemiol       Date:  2020-05-15       Impact factor: 3.254

8.  Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era.

Authors:  Salvatore De Rosa; Carmen Spaccarotella; Cristina Basso; Maria Pia Calabrò; Antonio Curcio; Pasquale Perrone Filardi; Massimo Mancone; Giuseppe Mercuro; Saverio Muscoli; Savina Nodari; Roberto Pedrinelli; Gianfranco Sinagra; Ciro Indolfi
Journal:  Eur Heart J       Date:  2020-06-07       Impact factor: 29.983

9.  The Italian health system and the COVID-19 challenge.

Authors:  Benedetta Armocida; Beatrice Formenti; Silvia Ussai; Francesca Palestra; Eduardo Missoni
Journal:  Lancet Public Health       Date:  2020-03-25

10.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

View more
  8 in total

1.  Optimization of the Use of Hospital Beds as an Example of Improving the Functioning of Hospitals in Poland on the Basis of the Provincial Clinical Hospital No. 1 in Rzeszow.

Authors:  Sławomir Porada; Katarzyna Sygit; Grażyna Hejda; Małgorzata Nagórska
Journal:  Int J Environ Res Public Health       Date:  2022-04-28       Impact factor: 4.614

Review 2.  Development of a Critical Care Response - Experiences from Italy During the Coronavirus Disease 2019 Pandemic.

Authors:  Emanuele Rezoagli; Aurora Magliocca; Giacomo Bellani; Antonio Pesenti; Giacomo Grasselli
Journal:  Anesthesiol Clin       Date:  2021-02-12

3.  The efficiency in the ordinary hospital bed management: A comparative analysis in four European countries before the COVID-19 outbreak.

Authors:  Fabrizio Pecoraro; Daniela Luzi; Fabrizio Clemente
Journal:  PLoS One       Date:  2021-03-22       Impact factor: 3.240

4.  An explainable machine learning framework for lung cancer hospital length of stay prediction.

Authors:  Belal Alsinglawi; Osama Alshari; Mohammed Alorjani; Omar Mubin; Fady Alnajjar; Mauricio Novoa; Omar Darwish
Journal:  Sci Rep       Date:  2022-01-12       Impact factor: 4.379

5.  Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey.

Authors:  Ergun Oksuz; Simten Malhan; Mustafa Sait Gonen; Zekayi Kutlubay; Yilmaz Keskindemirci; James Jarrett; Toros Sahin; Gokcem Ozcagli; Ahmet Bilgic; Merve Ozlem Bibilik; Fehmi Tabak
Journal:  Adv Ther       Date:  2021-08-11       Impact factor: 3.845

6.  Determinants of the risk of burnout among nurses during the first wave of the COVID-19 pandemic in Belgium: A cross-sectional study.

Authors:  Yasmine Khan; Arnaud Bruyneel; Pierre Smith
Journal:  J Nurs Manag       Date:  2022-04-28       Impact factor: 4.680

7.  Identification of High Death Risk Coronavirus Disease-19 Patients using Blood Tests.

Authors:  Elaheh Zadeh Hosseingholi; Saeede Maddahi; Sajjad Jabbari; Ghader Molavi
Journal:  Adv Biomed Res       Date:  2022-07-29

8.  COVID-19 and hospital management costs: the Italian experience.

Authors:  Emanuela Foglia; Lucrezia Ferrario; Fabrizio Schettini; M Beatrice Pagani; Martina Dalla Bona; Emanuele Porazzi
Journal:  BMC Health Serv Res       Date:  2022-08-04       Impact factor: 2.908

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.